129 related articles for article (PubMed ID: 37961863)
21. [Anti-inflammatory mechanism of
Zhang Y; Tu X; Zhang Y; Wen D; Zhao F; Yuan L; Li W
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):383-392. PubMed ID: 37087582
[TBL] [Abstract][Full Text] [Related]
22. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
[TBL] [Abstract][Full Text] [Related]
23. Network pharmacology mechanisms and experimental verification of licorice in the treatment of ulcerative colitis.
Kong J; Xiang Q; Ge W; Wang Y; Xu F; Shi G
J Ethnopharmacol; 2024 Apr; 324():117691. PubMed ID: 38176667
[TBL] [Abstract][Full Text] [Related]
24. Exploration of the Mechanisms Underlying Yu's Enema Formula in Treating Ulcerative Colitis by Blocking the RhoA/ROCK Pathway based on Network Pharmacology, High-performance Liquid Chromatography Analysis, and Experimental Verification.
Liu B; Zhang J; Wang X; Ye W; Yao J
Curr Pharm Des; 2024; 30(14):1085-1102. PubMed ID: 38523541
[TBL] [Abstract][Full Text] [Related]
25. Understanding apoptotic induction by Sargentodoxa cuneata-Patrinia villosa herb pair via PI3K/AKT/mTOR signalling in colorectal cancer cells using network pharmacology and cellular studies.
Mu BX; Li Y; Ye N; Liu S; Zou X; Qian J; Wu C; Zhuang Y; Chen M; Zhou JY
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117342. PubMed ID: 37879505
[TBL] [Abstract][Full Text] [Related]
26. In Silico and In Vivo Studies on the Mechanisms of Chinese Medicine Formula (Gegen Qinlian Decoction) in the Treatment of Ulcerative Colitis.
Liu X; Fan Y; Du L; Mei Z; Fu Y
Front Pharmacol; 2021; 12():665102. PubMed ID: 34177580
[TBL] [Abstract][Full Text] [Related]
27. Network pharmacological prediction of the mechanism of action of Shen-Zhu-Lian-Bai Decoction in the treatment of ulcerative colitis.
Zhu L; Liang J
Sci Rep; 2024 Jun; 14(1):14183. PubMed ID: 38902425
[TBL] [Abstract][Full Text] [Related]
28. Blockade of PI3K/AKT signaling pathway by Astragaloside IV attenuates ulcerative colitis via improving the intestinal epithelial barrier.
Zhang X; Zhang F; Li Y; Fan N; Zhao K; Zhang A; Kang J; Lin Y; Xue X; Jiang X
J Transl Med; 2024 Apr; 22(1):406. PubMed ID: 38689349
[TBL] [Abstract][Full Text] [Related]
29. Deciphering the pharmacological mechanisms of Fraxini Cortex for ulcerative colitis treatment based on network pharmacology and in vivo studies.
Wang T; Su X; Peng J; Tan X; Yang G; Zhang T; Chen F; Wang C; Ma K
BMC Complement Med Ther; 2023 May; 23(1):152. PubMed ID: 37161415
[TBL] [Abstract][Full Text] [Related]
30. Network pharmacology and pharmacokinetics integrated strategy to investigate the pharmacological mechanism of Xianglian pill on ulcerative colitis.
Liu CS; Xia T; Luo ZY; Wu YY; Hu YN; Chen FL; Tang QF; Tan XM
Phytomedicine; 2021 Feb; 82():153458. PubMed ID: 33486267
[TBL] [Abstract][Full Text] [Related]
31. [Pachymic acid protects against Crohn's disease-like intestinal barrier injury and colitis in miceby suppressingintestinal epithelial cell apoptosis
Shao R; Yang Z; Zhang W; Zhang N; Zhao Y; Zhang X; Zuo L; Ge S
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jun; 43(6):935-942. PubMed ID: 37439165
[TBL] [Abstract][Full Text] [Related]
32. The Mechanism of Polygonum Hydropiper L-Coptis Chinensis in the Treatment of Ulcerative Colitis Based on Network Pharmacology and Experimental Validation.
Zhu F; Zhi Y; Li Y; Niu H; Ren S
Front Biosci (Landmark Ed); 2024 Mar; 29(3):93. PubMed ID: 38538280
[TBL] [Abstract][Full Text] [Related]
33. Network Pharmacology and Molecular Docking Study of the Chinese Miao Medicine Sidaxue in the Treatment of Rheumatoid Arthritis.
Wu N; Yuan T; Yin Z; Yuan X; Sun J; Wu Z; Zhang Q; Redshaw C; Yang S; Dai X
Drug Des Devel Ther; 2022; 16():435-466. PubMed ID: 35221674
[TBL] [Abstract][Full Text] [Related]
34. Xiao-Luo-Wan treats propylthiouracil-induced goiter with hypothyroidism in rats through the PI3K-AKT/RAS pathways based on UPLC/MS and network pharmacology.
Dong S; Liu Q; Jiang M; Ma Q; Huang Q; Liu T; Li Y; Ni L; Shi Y
J Ethnopharmacol; 2022 May; 289():115045. PubMed ID: 35101570
[TBL] [Abstract][Full Text] [Related]
35. Wumei Wan attenuates angiogenesis and inflammation by modulating RAGE signaling pathway in IBD: Network pharmacology analysis and experimental evidence.
Duan ZL; Wang YJ; Lu ZH; Tian L; Xia ZQ; Wang KL; Chen T; Wang R; Feng ZY; Shi GP; Xu XT; Bu F; Ding Y; Jiang F; Zhou JY; Wang Q; Chen YG
Phytomedicine; 2023 Mar; 111():154658. PubMed ID: 36706698
[TBL] [Abstract][Full Text] [Related]
36. Deciphering the pharmacological mechanisms of Scutellaria baicalensis Georgi on oral leukoplakia by combining network pharmacology, molecular docking and experimental evaluations.
Hou F; Yu Z; Cheng Y; Liu Y; Liang S; Zhang F
Phytomedicine; 2022 Aug; 103():154195. PubMed ID: 35667260
[TBL] [Abstract][Full Text] [Related]
37. Bioactive triterpenoid compounds of Poria cocos (Schw.) Wolf in the treatment of diabetic ulcers via regulating the PI3K-AKT signaling pathway.
Ding X; Li S; Huang H; Shen J; Ding Y; Chen T; Ma L; Liu J; Lai Y; Chen B; Wang Y; Tan Q
J Ethnopharmacol; 2024 May; 325():117812. PubMed ID: 38301984
[TBL] [Abstract][Full Text] [Related]
38. Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke.
Zhao S; Zhang P; Yan Y; Xu W; Li J; Wang L; Wang N; Huang Y
J Ethnopharmacol; 2023 Aug; 312():116507. PubMed ID: 37080367
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of Key Ingredient of Astragalus membranaceus on Lung Adenocarcinoma via PI3K/AKT Signaling Clarified by Utilizing Network Pharmacology Approach and Experimental Validation.
Wang YC; Hui JR; Xiao G; Ma QL
Chin J Integr Med; 2023 Mar; 29(3):244-252. PubMed ID: 36044117
[TBL] [Abstract][Full Text] [Related]
40. Network pharmacology and
Wang M; Li J; Yin Y; Liu L; Wang Y; Qu Y; Hong Y; Ji S; Zhang T; Wang N; Liu J; Cao X; Zao X; Zhang S
Ann Med; 2022 Dec; 54(1):3219-3233. PubMed ID: 36382627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
